Limited information indicates that maternal doses of haloperidol up to 10 mg daily produce low levels in milk and usually do not affect the breastfed infant. Very limited long-term follow-up data indicate no adverse developmental effects when haloperidol is used alone. However, use with other antipsychotic drugs occasionally might negatively affect the infant. One expert guideline recommends against using haloperidol during breastfeeding,[1] but a safety scoring system finds haloperidol possible to use cautiously during breastfeeding.[2] Monitor the infant for drowsiness and developmental milestones, especially if other antipsychotics are used concurrently. Monitor infants exposed to haloperidol decanoate via human milk for excessive sedation, irritability, poor feeding, and extrapyramidal symptoms (tremors and abnormal muscle movements).
有限的信息表明，母亲每日服用高达10毫克的氟哌啶醇时，乳汁中的含量较低，通常不会影响母乳喂养的婴儿。非常有限的长期随访数据表明，单独使用氟哌啶醇时没有不良发育影响。然而，与其他抗精神病药物联合使用偶尔可能会对婴儿产生负面影响。一项专家指南建议在母乳喂养期间不要使用氟哌啶醇，[1]但一个安全评分系统发现氟哌啶醇在母乳喂养期间可能可以谨慎使用。[2]监测婴儿是否嗜睡以及发育里程碑情况，尤其是在同时使用其他抗精神病药物时。
